ABOUT IMMUNO CURE

Board of Directors

Andy Wong

Mr. Andy WONG

(Co-Founder)

Executive Director

 

Mr. Wong has over 20 years of management experience in pharmaceutical industry; lead M&A of innovative R&D start-up companies in medical device and new drug development; in charge of functions of compliance, quality, manufacturing, R&D projects, operation and new plant projects. Prior to joining the Company, he was the business advisor for a number of biotechnology and biomedical companies, which were supported by funding including China Investment Fund, the Innovation and Technology Fund under Hong Kong, Hong Kong Science Park incubation fund and listed pharmaceutical and medical companies in Hong Kong and the Mainland.

 

He was the Chief Operating Officer, Executive Vice President of Jacobson (stock code: 2633) from October 2016 to December 2019, a company listed on the main board of the Stock Exchange. He was responsible for managing the operation of manufacturing plants, research and development function and other project with various functions. From January 2015 to September 2016, he was the Executive Vice President in operation management of Jacobson. He also served as a vice president and general manager of the compliance and risk management department in Jacobson from February 2014 to January 2015 and September 2010 to January 2014 respectively.

 

Mr. Wong graduated from the City University of Hong Kong with a bachelor’s degree in science in analytical chemistry in 1995 and a master of philosophy in chemistry in 1997.